GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma

<div>Mice survival. Survival of mice with melanoma inoculated with BMDCs matured with TNF<i>α</i> and treated with MAGE-AX, GK-1, or MAGE-AX/GK-1. The MAGE-AX/GK-1 group was the one which had a higher survival rate: 40% up to 1.5 years after being inoculated with the BMCDs. It is followed by the GK-1, MAGE-AX, TNF<i>α</i>, and untreated group (WT), respectively.</div>

Journal of Immunology Research

fig3

Figure 3

Figure 3: GK-1 Improves the Immune Response Induced by Bone Marrow Dendritic Cells Loaded with MAGE-AX in Mice with Melanoma 